These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9925502)

  • 21. 2016 WHO Classification update-What's new in lymphoid neoplasms.
    Hsi ED
    Int J Lab Hematol; 2017 May; 39 Suppl 1():14-22. PubMed ID: 28447410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell death in hematological tumors.
    Fulda S
    Apoptosis; 2009 Apr; 14(4):409-23. PubMed ID: 19130230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematological malignancies: disease pathophysiology of leukemic stem cells.
    Ramdass B; Chowdhary A; Koka PS
    J Stem Cells; 2013; 8(3-4):151-87. PubMed ID: 24699024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Outline and direction of revised WHO classification of Tumors of Haematopoietic and Lymphoid Tissues].
    Tomonaga M
    Rinsho Ketsueki; 2009 Oct; 50(10):1401-6. PubMed ID: 19915348
    [No Abstract]   [Full Text] [Related]  

  • 25. What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites?
    Harris NL; Isaacson PG
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S126-32. PubMed ID: 9894477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    J Clin Oncol; 1999 Dec; 17(12):3835-49. PubMed ID: 10577857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report.
    Jaffe ES; Harris NL; Diebold J; Muller-Hermelink HK
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S8-12. PubMed ID: 9894466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow cytoplasmic buds and their association with hematologic neoplasms.
    Reardon MA; Tanaka KR
    Arch Pathol; 1972 Nov; 94(5):411-6. PubMed ID: 4507504
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunophenotyping of acute leukaemias and non-Hodgkin's lymphoma--review of ongoing consensus protocols.
    Höffkes HG; Brittinger G; Franke A
    Eur J Med Res; 1996 Jun; 1(9):433-8. PubMed ID: 9438140
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis of bone marrow disorders: is MRT sufficient?].
    Kramer J
    Radiologe; 2007 Aug; 47(8):660-2. PubMed ID: 17721793
    [No Abstract]   [Full Text] [Related]  

  • 31. Hematopoietic cancer and angiogenesis.
    Ribatti D; Scavelli C; Roccaro AM; Crivellato E; Nico B; Vacca A
    Stem Cells Dev; 2004 Oct; 13(5):484-95. PubMed ID: 15588506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic neoplasia in C57BL/6 mice exposed to split-dose ionizing radiation and circularly polarized 60 Hz magnetic fields.
    Babbitt JT; Kharazi AI; Taylor JM; Bonds CB; Mirell SG; Frumkin E; Zhuang D; Hahn TJ
    Carcinogenesis; 2000 Jul; 21(7):1379-89. PubMed ID: 10874017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the bone marrow microenvironment on hematopoietic malignancy.
    Askmyr M; Quach J; Purton LE
    Bone; 2011 Jan; 48(1):115-20. PubMed ID: 20541047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons to be learned from hematopoietic malignancies. Workshop report from the Division of Research Grants, National Institutes of Health.
    Matrisian LM; Tykocinski ML; Padarathsingh M
    Am J Pathol; 1995 Nov; 147(5):1519-21. PubMed ID: 7485414
    [No Abstract]   [Full Text] [Related]  

  • 35. [Advances in blastic plasmacytoid dendritic cell neoplasm].
    Fan XS; Wang SA
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):131-4. PubMed ID: 23710925
    [No Abstract]   [Full Text] [Related]  

  • 36. [Angiogenesis and hematological malignancies].
    Iversen PO
    Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3198-200. PubMed ID: 14714007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric analysis of cerebrospinal fluid has low diagnostic yield in samples without atypical morphology or prior history of hematologic malignancy.
    Collie AM; Hill BT; Stevens GH; Fenner K; Gazdick E; Hsi ED
    Am J Clin Pathol; 2014 Apr; 141(4):515-21. PubMed ID: 24619752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The extranodal lymphoid infiltrate: a diagnostic dilemma.
    Knowles DM
    Semin Diagn Pathol; 1985 Aug; 2(3):147-51. PubMed ID: 3916551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats.
    Frith CH; Ward JM; Chandra M
    Toxicol Pathol; 1993; 21(2):206-18. PubMed ID: 8210943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical and pathological features of patients with hematological neoplasms: a study of hospital-based Cancer Registry from western Turkey.
    Kilciksiz S; Pehlivan M; Yilmaz EB; Payzin B; Bener S; Baloglu A
    J BUON; 2011; 16(3):505-10. PubMed ID: 22006758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.